ESR1 and breast carcinoma: Because EGFR-ER interaction is associated with TAM resistance in breast cancer [10] and EGFR/ER signal cross-talk is bidirectional [12], we next tested if PTPH1 enhances the TKI-induced growth-inhibition by disrupting the EGFR-ER complex.